samsi, february 25, 2011

44
Dynamics Modeling as a Weapon to Defend Ourselves Against Threats from Infectious Diseases and Bioterrorist Attacks SAMSI, February 25, 2011 Hulin Wu, Ph.D., Professor Director, Center for Biodefense Immune Modeling Chief, Division of Biomedical Modeling and Informatics Department of Biostatistics & Computational Biology University of Rochester Medical Center

Upload: bao

Post on 06-Feb-2016

33 views

Category:

Documents


1 download

DESCRIPTION

Dynamics Modeling as a Weapon to Defend Ourselves Against Threats from Infectious Diseases and Bioterrorist Attacks. SAMSI, February 25, 2011. Hulin Wu, Ph.D., Professor Director, Center for Biodefense Immune Modeling Chief, Division of Biomedical Modeling and Informatics - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: SAMSI, February 25, 2011

Dynamics Modeling as a Weapon to Defend Ourselves Against Threats from

Infectious Diseases and Bioterrorist Attacks

SAMSI, February 25, 2011

Hulin Wu, Ph.D., ProfessorDirector, Center for Biodefense Immune Modeling

Chief, Division of Biomedical Modeling and Informatics

Department of Biostatistics & Computational BiologyUniversity of Rochester Medical Center

Page 2: SAMSI, February 25, 2011

Outline

• Introduction: Impact of Infectious Diseases to Public Health

• Dynamic Modeling for HIV

• Dynamic Modeling for Influenza

• Conclusions and Discussions

• Acknowledgement

Page 3: SAMSI, February 25, 2011

SARS Pandemic November 1, 2002-July 31, 2003

• Total Cases: 8096

• Death: 774

• Death rate: 9.6%

• 29 countries/regions

• USA: 27 cases (no death)

Page 4: SAMSI, February 25, 2011

Bird Flu (H5N1) Epidemics in Human

• Total Cases: 285

• Death: 170

• Death Rate: 59.6%

• 12 countries/regions

Page 5: SAMSI, February 25, 2011
Page 6: SAMSI, February 25, 2011

Flu Pandemics: History

• 1918 Spanish flu (H1N1) pandemic: kill 20-100 million people worldwide

• 1957 Asian Flu (H2N2): 1-4 million infections worldwide, 69,800 deaths in the US

• 1968 Hong Kong Flu (H3N2): 500,000 infections worldwide, 33,000 deaths in the US

Page 7: SAMSI, February 25, 2011

An Emergency Hospital for Influenza Patients

Page 8: SAMSI, February 25, 2011

Annual Influenza Epidemics around the World

• 5-15% of the population affected

• 3-5 million cases of severe illness

• 250,000-500,000 deaths around the world

Page 9: SAMSI, February 25, 2011

Current Estimates of the Yearly Disease Burden of Influenza in the US

40,000100,000

40,000,0004,000,000,0008,000,000,000

Deaths -Hospitalizations -Illnesses -Direct costs ($) -Indirect costs ($) -

Page 10: SAMSI, February 25, 2011

Global HIV/AIDS Epidemics: 2006 Update

Page 11: SAMSI, February 25, 2011

Global HIV/AIDS Epidemics: 2006 Update

Page 12: SAMSI, February 25, 2011

Global HIV/AIDS Epidemics: 2006 Update

Page 13: SAMSI, February 25, 2011

New HIV Infection Rate in 2006

• 8 infections per minute

• 458 infections per hour

Page 14: SAMSI, February 25, 2011

Defend Ourselves: Why and How to Use Mathematics/Statistics as a Weapon?

• Understand pathogenesis of infection by infectious agents

• Identify therapeutic targets for intervention

• Design and evaluate the effects of treatments and other intervention/prevention strategies

Page 15: SAMSI, February 25, 2011

Example: HIV/AIDS Modeling

• 1st AIDS case: reported in late 1970s

• AIDS virus: discovered in 1983, named HTLV

• AIDS virus renamed as HIV in 1986

• HIV dynamics models in late 1980s: Merrill 1987; Mclean 1988; Anderson and May 1989; Perelson 1989

• HIV dynamics models for clinical studies: David Ho and Alan Perelson (Nature 1995; Science 1996; Nature 1997)

• My research in HIV dynamics modeling: 1997-

Page 16: SAMSI, February 25, 2011

Ho et al, Nature 1995

Page 17: SAMSI, February 25, 2011

Ho et al., Nature 1995

• 20 HIV-1 infected patients

• A new antiviral drug: a protease inhibitor, ABT-538 (Ritonavir)

• Observations: Viral load declined exponentially in 2 weeks

Page 18: SAMSI, February 25, 2011

Ho et al., Nature 1995

Page 19: SAMSI, February 25, 2011

Ho et al., Nature 1995

• Tap-Tank Model

• Solution with perfect treatment P=0

• Fit a linear regression model

c: viral clearance rate

1/c: Mean life-span of HIV virus

ln(2/c): Half-life of HIV virus

/dV dt P cV

0 0( ) log ( ) logctV t V e or V t V ct

0( ) logY t V ct

Page 20: SAMSI, February 25, 2011

Ho et al., Nature 1995

• Estimate of c: 0.34 (range 0.21 to 0.54)

• Half-life of HIV virus: 2.1 (range1.3 to 3.3) days

• Daily production and clearance rate of HIV virus: 0.68x10^9 (range 0.05 to 2.07x10^9) virions

Page 21: SAMSI, February 25, 2011
Page 22: SAMSI, February 25, 2011

Perelson et al. and Ho, Science 1996

• A more complicated model

• Solution

• Clinical data: 5 HIV patients

* / *

/

/ *

I

I I

NI NI

dT dt kV T

dV dt cV

dV dt N T cV

00 [ ( ) ]ct t ct ct

I NI

cV cY V V V e e e te

c c

Page 23: SAMSI, February 25, 2011

Perelson et al. and Ho, Science 1996

• Estimate of c: 3.07

• Estimate of δ: 0.49

• Half-life of virus: 0.24 (about 6 hours).

• Half-life of infected cells: 1.55 days

Page 24: SAMSI, February 25, 2011
Page 25: SAMSI, February 25, 2011

Perelson et al. and Ho, Nature 1997

• Short-lived infected cells: t1/2=1.1 days

• Long-lived inected cells: t1/2=14.1 days

• Latently infected cells: t1/2=8.5 days

Page 26: SAMSI, February 25, 2011
Page 27: SAMSI, February 25, 2011

My Research: HIV and Influenza

• HIV/AIDS: Use differential equation models to study antiretroviral treatment effects and treatment strategies in HIV/AIDS research

• Influenza: Use differential equation models to study immune response to influenza infections and vaccinations

Page 28: SAMSI, February 25, 2011

Dynamic Models for AIDS Treatment

• HIV Viral Dynamic Model in Vivo

• Viral fitness is related to antiviral drug efficacy• Correlate the lab data to clinical data via the

proposed model

Page 29: SAMSI, February 25, 2011
Page 30: SAMSI, February 25, 2011
Page 31: SAMSI, February 25, 2011
Page 32: SAMSI, February 25, 2011

Influenza Project

• Center for Biodefense Immune Modeling: funded by NIH from 2005-2015 with $21.9 million in total

• To develop mathematical models and computer simulation tools to simulate immune response to influenza virus

• To design and conduct experiments to validate the mathematical models and simulation tools

• To expect that our modeling and simulation tools can help to rapidly design drugs or vaccines to fight against new and possibly engineered viruses

Page 33: SAMSI, February 25, 2011
Page 34: SAMSI, February 25, 2011

A Complex Dynamic System for Influenza Infection: Lee et al 2009 (J. of Virology)

6/26/09 Annual Meeing

6/2/10 Annual Meeting

Page 35: SAMSI, February 25, 2011

Lung Compartment Sub-Model

** * *

*

( )

( ) ( )

p E p P

p P E P E pE

P V VG G VM M

dE E E V

dtdE E V k E T t E

dtdV E c V k VA t k VA t

dt

Page 36: SAMSI, February 25, 2011

Lung Compartment Sub-Model

Fig 1. HKX31 EID50/ml titers per murine lung

0

2

4

6

8

10

0 5 10 15Days

Vir

al T

iter

(lo

g10

)

Collected data

Fig 2. Cytokine secreting CD8+ T cells per murine lung

Page 37: SAMSI, February 25, 2011

6/26/09 Annual Meeting

Lung Compartment Sub-Model

Fig 3. Smoothed data for IgG and IgM pg/ml murine serum

Collected data

Page 38: SAMSI, February 25, 2011

Model Fitting Results

Page 39: SAMSI, February 25, 2011

Estimation Result Summary

– The CTL effect: 6.4x10-5/day. Shorten the half-life of infected cells from 1.16 days to 0.59 days in average.

– The death rate of infected cells due to effects other than CTL is 0.16/day which is 26% of the death rate during the first 5 days

– Antibody effect: IgM dominates the clerance of viral particles with a rate about 4.4/day. Shorten the half-life from 4 hours to 1.8 minutes in average

– Antibody IgG: not significant

– The clearance rate of viral particles due to factors other than antibody effect: very small.

Page 40: SAMSI, February 25, 2011

Immune Response Kinetics: Useful

• Identify antiviral drug and vaccine targets

• Understand virulent viruses and their properties

• Prepareness

Page 41: SAMSI, February 25, 2011

42

DEDiscover

Software tool for developing, exploring, and applying differential equation models.

Key Features:• ODE & DDE Models• “Real-time” interactive simulation• Data fitting (Estimation)• Clean, Cross-platform GUI• High Quality Plots• Ver 2.5b: freely available

https://cbim.urmc.rochester.edu/software/dediscover

2010-06-02 CBIM DEDiscover Software

Page 42: SAMSI, February 25, 2011

Conclusions and Discussions

• Efficiently fight against infectious diseases and bioterrorism: – Need global effort with efficient collaborations and

communications– Need efficient collaborations and communications

among inter-disciplinary scientists– Need long-term effort and huge resources

• Use any weapons available to defend ourselves including mathematics, computer and statistics

• Dynamics modeling: an important weapon• Can we defend ourselves?

Page 43: SAMSI, February 25, 2011
Page 44: SAMSI, February 25, 2011

Acknowledgments

• NIAID/NIH grant R01 AI 055290: AIDS Clinical Trial Modeling and Simulations

• NIAID/NIH grant N01 AI50020: Center for Biodefense Immune Modeling

• NIAID/NIH grant P30 AI078498: Developmental Center for AIDS Research

• NIAID/NIH grant R21 AI078842: Analysis of Differential Resistance Emergence Risk for Differential Treatment Applications

• NIAID/NIH grant RO1 AI087135: Estimation Methods for Nonlinear ODE Models in AIDS Research